{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:09:29Z","timestamp":1790564969200,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The prevalence of idiopathic pulmonary fibrosis (IPF) is higher in men, a previously not well-understood sex bias that extends across severity and mortality. Mosaic loss of chromosome Y (mLOY) in blood is male-specific and associated with adverse outcomes, including IPF. In mLOY-mice, enhanced TGF-\u03b2 signaling has been reported to contribute to fibrosis of internal organs, but it is not known if such mLOY-driven disease mechanism exists in humans.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We focused here on IPF in men to investigate if mLOY contributes to fibrotic disease processes in humans, as demonstrated in mouse models. To this end, we investigated mLOY as a risk factor for male IPF in epidemiological and clinical datasets, as well as by re-analyses of published single-cell RNA sequencing (scRNAseq) datasets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We find that men with mLOY in blood display an increased risk for IPF diagnosis and death caused by IPF in UK Biobank, and that mLOY is associated with reduced lung functions in two cohorts. Approximately 80% of the male excess in IPF prevalence occurs in the group of men with mLOY in blood leukocytes. Notably, scRNAseq analyses support that pulmonary leukocytes with Y loss exacerbate IPF by upregulating profibrotic genes and enhancing TGF-\u03b2 signaling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results contribute to explaining the profound sex bias in IPF and replicate a mLOY-driven profibrotic disease mechanism first identified in mice. Male IPF patients with mLOY represent a subgroup that may benefit from treatment with TGF-\u03b2 inhibitors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s43856-025-00966-9","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T10:22:49Z","timestamp":1751106169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7675-429X","authenticated-orcid":false,"given":"Josefin","family":"Bjurling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Chavkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"Halvardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Thel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Zaghlool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-9480","authenticated-orcid":false,"given":"Shwu-Fan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-3182","authenticated-orcid":false,"given":"Fernando J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Noth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-2276","authenticated-orcid":false,"given":"Kenneth","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-755X","authenticated-orcid":false,"given":"Lars A.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"966_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","volume":"378","author":"DJ Lederer","year":"2018","unstructured":"Lederer, D. J. & Martinez, F. J. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 378, 1811\u20131823 (2018).","journal-title":"N. Engl. J. Med."},{"key":"966_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao, M. et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct. Target. Ther. 7, 206 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"966_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chest.2020.02.009","volume":"158","author":"T Zaman","year":"2020","unstructured":"Zaman, T. et al. Differences in clinical characteristics and outcomes between men and women with idiopathic pulmonary fibrosis: a multicenter retrospective cohort study. Chest 158, 245\u2013251 (2020).","journal-title":"Chest"},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1164\/rccm.201905-1017OC","volume":"201","author":"RJ Allen","year":"2020","unstructured":"Allen, R. J. et al. Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 201, 564\u2013574 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"713698","DOI":"10.3389\/fmed.2021.713698","volume":"8","author":"L Sese","year":"2021","unstructured":"Sese, L. et al. Gender differences in idiopathic pulmonary fibrosis: are men and women equal? Front. Med. 8, 713698 (2021).","journal-title":"Front. Med."},{"key":"966_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30759-1","volume":"8","author":"E Loftfield","year":"2018","unstructured":"Loftfield, E. et al. Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank. Sci. Rep. 8, 12316 (2018).","journal-title":"Sci. Rep."},{"key":"966_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng.2966","volume":"46","author":"LA Forsberg","year":"2014","unstructured":"Forsberg, L. A. et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat. Genet. 46, 624\u2013628 (2014).","journal-title":"Nat. Genet."},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.abn3100","volume":"377","author":"S Sano","year":"2022","unstructured":"Sano, S. et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science 377, 292\u2013297 (2022).","journal-title":"Science"},{"key":"966_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrg.2016.145","volume":"18","author":"LA Forsberg","year":"2017","unstructured":"Forsberg, L. A., Gisselsson, D. & Dumanski, J. P. Mosaicism in health and disease - clones picking up speed. Nat. Rev. Genet. 18, 128\u2013142 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"966_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-019-1765-3","volume":"575","author":"DJ Thompson","year":"2019","unstructured":"Thompson, D. J. et al. Genetic predisposition to mosaic Y chromosome loss in blood. Nature 575, 652\u2013657 (2019).","journal-title":"Nature"},{"key":"966_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/science.1262092","volume":"347","author":"JP Dumanski","year":"2015","unstructured":"Dumanski, J. P. et al. Smoking is associated with mosaic loss of chromosome Y. Science 347, 81\u201383 (2015).","journal-title":"Science"},{"key":"966_CR12","doi-asserted-by":"publisher","DOI":"10.1289\/EHP12834","volume":"131","author":"VC Chang","year":"2023","unstructured":"Chang, V. C. et al. Glyphosate use and mosaic loss of chromosome y among male farmers in the Agricultural Health Study. Environ. Health Perspect. 131, 127006 (2023).","journal-title":"Environ. Health Perspect."},{"key":"966_CR13","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00018-021-03822-w","volume":"78","author":"JP Dumanski","year":"2021","unstructured":"Dumanski, J. P. et al. Immune cells lacking Y chromosome show dysregulation of autosomal gene expression. Cell. Mol. Life Sci. 78, 4019\u20134033 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"966_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94588-5","volume":"11","author":"J Mattisson","year":"2021","unstructured":"Mattisson, J. et al. Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99. Sci. Rep. 11, 15160 (2021).","journal-title":"Sci. Rep."},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","volume":"606","author":"E Mitchell","year":"2022","unstructured":"Mitchell, E. et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature 606, 343\u2013350 (2022).","journal-title":"Nature"},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.ajhg.2016.05.014","volume":"98","author":"JP Dumanski","year":"2016","unstructured":"Dumanski, J. P. et al. Mosaic loss of chromosome Y in blood is associated with Alzheimer disease. Am. J. Hum. Genet. 98, 1208\u20131219 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"966_CR17","doi-asserted-by":"crossref","unstructured":"Mas-Peiro, S. et al. Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement. Eur. Heart J. 44, 1943\u20131952 (2023).","DOI":"10.1093\/eurheartj\/ehad093"},{"key":"966_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/gcc.22282","volume":"54","author":"C Ganster","year":"2015","unstructured":"Ganster, C. et al. New data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes. Genes Chromosomes Cancer 54, 717\u2013724 (2015).","journal-title":"Genes Chromosomes Cancer"},{"key":"966_CR19","doi-asserted-by":"publisher","first-page":"2400968","DOI":"10.1183\/13993003.00968-2024","volume":"64","author":"C Weng","year":"2024","unstructured":"Weng, C. et al. Mosaic loss of chromosome Y, tobacco smoking and risk of age-related lung diseases: insights from two prospective cohorts. Eur. Respir. J. 64, 2400968 (2024).","journal-title":"Eur. Respir. J."},{"key":"966_CR20","doi-asserted-by":"publisher","first-page":"2401303","DOI":"10.1183\/13993003.01303-2024","volume":"64","author":"M Espinosa","year":"2024","unstructured":"Espinosa, M. et al. Determination of loss of chromosome Y in peripheral blood cells in males with idiopathic pulmonary fibrosis. Eur. Respir. J. 64, 2401303 (2024).","journal-title":"Eur. Respir. J."},{"key":"966_CR21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMra1300575","volume":"372","author":"DC Rockey","year":"2015","unstructured":"Rockey, D. C., Bell, P. D. & Hill, J. A. Fibrosis\u2013a common pathway to organ injury and failure. N. Engl. J. Med. 372, 1138\u20131149 (2015).","journal-title":"N. Engl. J. Med."},{"key":"966_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).","journal-title":"PLoS Med."},{"key":"966_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41431-019-0533-z","volume":"28","author":"M Danielsson","year":"2020","unstructured":"Danielsson, M. et al. Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals. Eur. J. Hum. Genet. 28, 349\u2013357 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"966_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13578-021-00716-z","volume":"11","author":"M Riaz","year":"2021","unstructured":"Riaz, M. et al. A polygenic risk score predicts mosaic loss of chromosome Y in circulating blood cells. Cell Biosci. 11, 205 (2021).","journal-title":"Cell Biosci."},{"key":"966_CR25","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1001\/jama.2021.4956","volume":"325","author":"FJ Martinez","year":"2021","unstructured":"Martinez, F. J. et al. Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial. JAMA 325, 1841\u20131851 (2021).","journal-title":"JAMA"},{"key":"966_CR26","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir. Crit. Care Med. 205, e18\u2013e47 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse, C. et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. 54, 1802441 (2019).","journal-title":"Eur. Respir. J."},{"key":"966_CR28","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","volume":"199","author":"PA Reyfman","year":"2019","unstructured":"Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1517\u20131536 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"966_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1983","volume":"6","author":"TS Adams","year":"2020","unstructured":"Adams, T. S. et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci. Adv. 6, eaba1983 (2020).","journal-title":"Sci. Adv."},{"key":"966_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1972","volume":"6","author":"AC Habermann","year":"2020","unstructured":"Habermann, A. C. et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci. Adv. 6, eaba1972 (2020).","journal-title":"Sci. Adv."},{"key":"966_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/cvr\/cvac139","volume":"119","author":"LPMH de Rooij","year":"2022","unstructured":"de Rooij, L. P. M. H. et al. The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution. Cardiovasc. Res. 119, 520\u2013535 (2022).","journal-title":"Cardiovasc. Res."},{"key":"966_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson, M. et al. A single\u2013cell type transcriptomics map of human tissues. Sci. Adv. 7, eabh2169 (2021).","journal-title":"Sci. Adv."},{"key":"966_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\u201344 (2019).","journal-title":"Nat. Biotechnol."},{"key":"966_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","volume":"106","author":"LX Wang","year":"2019","unstructured":"Wang, L. X., Zhang, S. X., Wu, H. J., Rong, X. L. & Guo, J. M2b macrophage polarization and its roles in diseases. J. Leukoc. Biol. 106, 345\u2013358 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"966_CR35","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1182\/blood-2012-06-436212","volume":"121","author":"FO Martinez","year":"2013","unstructured":"Martinez, F. O. et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 121, e57\u2013e69 (2013).","journal-title":"Blood"},{"key":"966_CR36","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1189\/jlb.1012512","volume":"93","author":"ML Novak","year":"2013","unstructured":"Novak, M. L. & Koh, T. J. Macrophage phenotypes during tissue repair. J. Leukoc. Biol. 93, 875\u2013881 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"966_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"966_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1165\/rcmb.2018-0313OC","volume":"61","author":"R Peyser","year":"2019","unstructured":"Peyser, R. et al. Defining the activated fibroblast population in lung fibrosis using single-cell sequencing. Am. J. Respir. Cell Mol. Biol. 61, 74\u201385 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"966_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s44161-024-00441-z","volume":"3","author":"K Horitani","year":"2024","unstructured":"Horitani, K. et al. Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure. Nat. Cardiovasc. Res. 3, 343\u2013355 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"966_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1589\/jpts.26.167","volume":"26","author":"A Tantisuwat","year":"2014","unstructured":"Tantisuwat, A. & Thaveeratitham, P. Effects of smoking on chest expansion, lung function, and respiratory muscle strength of youths. J. Phys. Ther. Sci. 26, 167\u2013170 (2014).","journal-title":"J. Phys. Ther. Sci."},{"key":"966_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-024-10168-7","volume":"25","author":"J Mattisson","year":"2024","unstructured":"Mattisson, J. et al. Loss of chromosome Y in regulatory T cells. BMC Genomics 25, 243 (2024).","journal-title":"BMC Genomics"},{"key":"966_CR42","doi-asserted-by":"publisher","unstructured":"Wang, D. et al. Association between mosaic loss of chromosome Y and pulmonary fibrosis susceptibility and severity. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.05.25.595885 (2024).","DOI":"10.1101\/2024.05.25.595885"},{"key":"966_CR43","doi-asserted-by":"publisher","first-page":"180033","DOI":"10.1183\/16000617.0033-2018","volume":"27","author":"C Upagupta","year":"2018","unstructured":"Upagupta, C., Shimbori, C., Alsilmi, R. & Kolb, M. Matrix abnormalities in pulmonary fibrosis. Eur. Respir. Rev. 27, 180033 (2018).","journal-title":"Eur. Respir. Rev."},{"key":"966_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56955-1","volume":"9","author":"EJ Walker","year":"2019","unstructured":"Walker, E. J., Heydet, D., Veldre, T. & Ghildyal, R. Transcriptomic changes during TGF-beta-mediated differentiation of airway fibroblasts to myofibroblasts. Sci. Rep. 9, 20377 (2019).","journal-title":"Sci. Rep."},{"key":"966_CR45","doi-asserted-by":"publisher","first-page":"1230266","DOI":"10.3389\/fimmu.2023.1230266","volume":"14","author":"J Lv","year":"2023","unstructured":"Lv, J. et al. Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis. Front. Immunol. 14, 1230266 (2023).","journal-title":"Front. Immunol."},{"key":"966_CR46","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1073\/pnas.78.11.7147","volume":"78","author":"SI Rennard","year":"1981","unstructured":"Rennard, S. I., Hunninghake, G. W., Bitterman, P. B. & Crystal, R. G. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc. Natl. Acad. Sci. USA 78, 7147\u20137151 (1981).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"966_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112131","volume":"42","author":"K Hoeft","year":"2023","unstructured":"Hoeft, K. et al. Platelet-instructed SPP1(+) macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner. Cell Rep. 42, 112131 (2023).","journal-title":"Cell Rep."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00966-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00966-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00966-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T11:03:15Z","timestamp":1751108595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00966-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00966-9","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}